These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3014277)

  • 1. Protective effects of nasal immunization in mice with various kinds of inactivated Sendai virus vaccines.
    Miyamae T
    Microbiol Immunol; 1986; 30(3):213-23. PubMed ID: 3014277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional differences of dyes in inducing respiratory immunogenicity by azo-, thiazole-, quinoline-, reactive-, and naphthol-dye-inactivated Sendai viruses.
    Miyamae T
    Microbiol Immunol; 1993; 37(3):213-20. PubMed ID: 8391624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducement of respiratory mucosal immunogenicity for nasal vaccine due to amine- and amide-inactivation of parainfluenza virus type 1, Sendai.
    Miyamae T
    Microbiol Immunol; 1994; 38(12):937-41. PubMed ID: 7723686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined oral/nasal immunization protects mice from Sendai virus infection.
    Nedrud JG; Liang XP; Hague N; Lamm ME
    J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation on mouse nasal immunogenicity of arylmethane-, xanthene-, quinone-imine-, and acridine-dye-inactivated Sendai virus vaccines.
    Miyamae T
    Microbiol Immunol; 1990; 34(4):367-75. PubMed ID: 2163484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further search for small molecular inactivants capable of eliciting respiratory mucosal immunogenicity by modifying Sendai virus core RNA.
    Miyamae T
    Microbiol Immunol; 1996; 40(10):761-6. PubMed ID: 8981350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of intranasal vaccination with subunit Sendai virus vaccine in mice.
    Ito H; Matumoto M
    Jpn J Exp Med; 1986 Jun; 56(3):125-9. PubMed ID: 3020282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a protease activation mutant of Sendai virus as a potent live vaccine.
    Maru M; Haraguchi M; Sato K; Hotta H; Homma M
    Vet Microbiol; 1992 Jan; 30(1):1-12. PubMed ID: 1311131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescent examination of the nasal mucous membrane of mouse in prophylactic trials against Sendai virus.
    Miyamae T
    Nihon Juigaku Zasshi; 1984 Apr; 46(2):133-9. PubMed ID: 6087004
    [No Abstract]   [Full Text] [Related]  

  • 10. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of the most efficacious of twenty-two inactivated Sendai virus nasal vaccines by determination of the protection index in mice.
    Miyamae T
    Lab Anim Sci; 1999 Apr; 49(2):149-52. PubMed ID: 10331544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of protective effects of serum antibody on respiratory and systemic infection of Sendai virus in mice.
    Tashiro M; Tobita K; Seto JT; Rott R
    Arch Virol; 1989; 107(1-2):85-96. PubMed ID: 2552964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a temperature-sensitive Sendai virus vaccine in hamsters.
    Tagaya M; Mori I; Miyadai T; Kimura Y; Ito H; Nakakuki K
    Lab Anim Sci; 1995 Jun; 45(3):233-8. PubMed ID: 7650890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse nasal immunogenicity of Sendai virus vaccines inactivated by chemical modification of core RNA.
    Miyamae T
    Nihon Juigaku Zasshi; 1987 Dec; 49(6):1097-103. PubMed ID: 2828733
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective effect of inactivated virus vaccine on Sendai virus infection in rats.
    Tsukui M; Ito H; Tada M; Nakata M; Miyajima H; Fujiwara K
    Lab Anim Sci; 1982 Apr; 32(2):143-6. PubMed ID: 6281572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of protective immune responses against Sendai virus infection by fungal polysaccharide schizophyllan.
    Hotta H; Hagiwara K; Tabata K; Ito W; Homma M
    Int J Immunopharmacol; 1993 Jan; 15(1):55-60. PubMed ID: 7679379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of mice against virulent virus infection by a temperature-sensitive mutant derived from an HVJ (Sendai virus) carrier culture.
    Kimura Y; Aoki H; Shimokata K; Ito Y; Takano M; Hirabayashi N; Norrby E
    Arch Virol; 1979; 61(4):297-304. PubMed ID: 229796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunization with Sendai virus in mice.
    Nedrud JG; Liang XP; Lamm ME
    Curr Top Microbiol Immunol; 1989; 146():117-22. PubMed ID: 2543541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
    Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
    J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
    Liang XP; Lamm ME; Nedrud JG
    J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.